A type 2 biomarker separates relapsing-remitting from secondary progressive multiple sclerosis. Dickens AM, Larkin JR, Griffin JL, Cavey A, Matthews L, Turner MR, Wilcock GK, Davis BG, Claridge TDW, Palace J, et al. Neurology. 2014 Sep 24. PMID: 25253748. Abstract CommentRecommendBookmarkWatch